
ACS Catalysis p. 1446 - 1451 (2017)
Update date:2022-08-11
Topics:
Ashley, Eric R.
Sherer, Edward C.
Pio, Barbara
Orr, Robert K.
Ruck, Rebecca T.
Chiral chroman derivatives are important pharmacophores in natural and synthetic bioactive molecules. The discovery of catalytic asymmetric methods for the synthesis of these compounds is an important goal. Ruthenium-catalyzed asymmetric transfer hydrogenation under strongly basic conditions has been found to induce dynamic kinetic resolution of β-substituted chromanones, producing valuable chromanols in high yields and with high levels of stereocontrol. The reaction proceeds by base-catalyzed racemization of the β-stereocenter through a conjugate elimination/conjugate addition pathway in concert with a highly selective ketone transfer hydrogenation step. Computational analysis of the catalyst, substrate, and transition state structures has revealed the driving interactions for diastereoselectivity as well as unexpected CH-O stabilizing interactions between the catalyst sulfonamide and the reacting substrate.
Xian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-88211911
Address:Keji Road NO.70
shanghai meicheng chemical co .,ltd(expird)
Contact:+86-21-50677091
Address:Room 302, Building 7, No.1000, Jinhai Road
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
ShangHai BMG Chemical Co., Ltd
Contact:+86-13524845543
Address:Room 602, no 291 sikai road shanghai
Doi:10.1021/jo961840s
(1997)Doi:10.1021/jm501179r
(2014)Doi:10.1021/acs.oprd.5b00245
(2016)Doi:10.1002/cssc.201402157
(2014)Doi:10.1002/jlac.19707400120
(1970)Doi:10.1021/ja00762a009
(1972)